Medical Blog About Treatment Abroad

Prostate cancer remains the most widespread oncological pathology among men and a leading cause of cancer death worldwide. According to epidemiological data, PCa is the most frequently diagnosed cancer among men in more than half of the countries in the world (112 of 185 countries/territories), with an estimated 1.4 million new...

Osteosarcoma tumors are a rare but aggressive form of bone cancer, most commonly affecting adolescents and young adults. In Germany, approximately 60 children and adolescents under 18 are diagnosed with osteosarcoma each year, accounting for about 2.6% of all pediatric malignancies in this age group. This cancer typically...

Breast cancer (BCa) affects more than 2 million women each year, and approximately 10 percent of the cases are diagnosed with stage 4 and metastases. German hospitals are the best providers of cancer treatment, as the most effective ones due to the combination of innovative technology with holistic treatment of the patient.

Soft tissue sarcomas are rare malignant tumors that develop in muscles, fat, cartilage, blood vessels, and other non-epithelial tissues throughout the body. With approximately 13,520 new cases expected in the United States in 2025, these cancers represent less than 1% of all cancer diagnoses. While advanced sarcomas differ...

Prostate cancer immunotherapy represents a breakthrough in cancer treatment that's showing remarkable results across various disease stages. Immunotherapy works where other treatments have failed and can no longer stop cancer progression. While traditionally considered for advanced cases, recent clinical evidence demonstrates...

Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year. This tumor accounts for 3% of all cancers, which is a fairly high figure. The treatment methods offered in Germany allow for achieving excellent results, even at stage 4 of the pathology.

Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...

Colorectal cancer (CRC) is a significant public health concern in Germany, ranking among the most commonly diagnosed cancers. In 2022, approximately 24,650 women and 29,960 men were newly diagnosed with CRC. The incidence rates are notably higher in individuals over the age of 55, with the majority of cases originating in the colon...